Cochrane · systematic review · CD004121
Non‐steroidal anti‐inflammatory agents to induce regression and prevent the progression of cervical intraepithelial neoplasia
Grabosch, SM, Shariff, OM, Helm, CW · Cochrane Database of Systematic Reviews · 2018 · Cochrane Library
SoF tableOnly the outcomes this review put in its Summary of Findings table are listed (the Cochrane Handbook caps them at about seven per comparison). Its other analyses are not shown here.
Questions
3
current version
GRADE rated
3
No studies
0
Included studies
NR
No studies 0 · 0%Ungraded 0 · 0%Very low 1 · 33.3%Low 0 · 0%Moderate 2 · 66.7%High 0 · 0%
Ungraded means an effect was reported without a GRADE rating; it is not a gap. No studies means the review found nothing to answer the question. The six categories are a display order, not a score.
Questions and results
Current version onlyComparison
Population: women with CIN 2 or CIN 3
| Outcome | Effect | Evidence | Status / GRADE |
|---|---|---|---|
Progression of CIN to a higher grade of CIN | RR 0.54 [0.06, 5.24] | 25 participants | Very low Downgraded: imprecision |
Partial or complete regression of CIN 2 or CIN 3 | RR 1.45 [0.93, 2.27] | 132 participants | Moderate Downgraded: imprecision |
Complete regression of CIN 2 or CIN 3 | RR 1.31 [0.65, 2.67] | 116 participants | Moderate Downgraded: imprecision |
Comparison
Population: women with CIN 2 or CIN 3
| Outcome | Effect | Evidence | Status / GRADE |
|---|---|---|---|
Complete regression of CIN 2 or CIN 3 | RR 2.17 [0.48, 9.76] | 25 participants | Very low Downgraded: imprecision |
Partial or complete regression of CIN 2 or CIN 3 | RR 2.35 [1.03, 5.35] | 41 participants | Very low Downgraded: imprecision |
Progression of CIN to a higher grade of CIN | RR 0.54 [0.06, 5.24] | 25 participants | Very low Downgraded: imprecision |